vs
Harmony Biosciences Holdings, Inc.（HRMY）与ROYAL GOLD INC（RGLD）财务数据对比。点击上方公司名可切换其他公司
ROYAL GOLD INC的季度营收约是Harmony Biosciences Holdings, Inc.的1.5倍（$375.3M vs $243.8M），ROYAL GOLD INC净利率更高（24.9% vs 9.2%，领先15.7%），ROYAL GOLD INC同比增速更快（85.3% vs 21.1%），过去两年ROYAL GOLD INC的营收复合增速更高（58.8% vs 25.6%）
哈莫尼生物科学控股公司是一家处于商业化阶段的生物制药企业，专注于罕见神经及中枢神经系统疾病创新疗法的研发与商业化，核心产品针对发作性睡病等睡眠相关中枢神经系统病症，主要市场为美国。
Royal Gold Inc.是全球领先的贵金属流权与特许权经营企业，收购并管理多元化的矿业项目流权、净熔炼收益特许权及相关权益，资产覆盖黄金、白银、铜等品类，业务遍及多地区，无需直接承担采矿运营风险。
HRMY vs RGLD — 直观对比
营收规模更大
RGLD
是对方的1.5倍
$243.8M
营收增速更快
RGLD
高出64.2%
21.1%
净利率更高
RGLD
高出15.7%
9.2%
两年增速更快
RGLD
近两年复合增速
25.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $243.8M | $375.3M |
| 净利润 | $22.5M | $93.6M |
| 毛利率 | 71.9% | 64.6% |
| 营业利润率 | 15.8% | 56.2% |
| 净利率 | 9.2% | 24.9% |
| 营收同比 | 21.1% | 85.3% |
| 净利润同比 | -54.6% | -12.8% |
| 每股收益（稀释后） | $0.38 | $1.04 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HRMYRGLD
| Q4 25 | $243.8M | $375.3M | ||
| Q3 25 | $239.5M | $252.1M | ||
| Q2 25 | $200.5M | $209.6M | ||
| Q1 25 | $184.7M | $193.4M | ||
| Q4 24 | $201.3M | $202.6M | ||
| Q3 24 | $186.0M | $193.8M | ||
| Q2 24 | $172.8M | $174.1M | ||
| Q1 24 | $154.6M | $148.9M |
净利润HRMYRGLD
| Q4 25 | $22.5M | $93.6M | ||
| Q3 25 | $50.9M | $126.8M | ||
| Q2 25 | $39.8M | $132.3M | ||
| Q1 25 | $45.6M | $113.5M | ||
| Q4 24 | $49.5M | $107.4M | ||
| Q3 24 | $46.1M | $96.2M | ||
| Q2 24 | $11.6M | $81.2M | ||
| Q1 24 | $38.3M | $47.2M |
毛利率HRMYRGLD
| Q4 25 | 71.9% | 64.6% | ||
| Q3 25 | 75.1% | 73.6% | ||
| Q2 25 | 81.0% | 72.6% | ||
| Q1 25 | 82.7% | 69.4% | ||
| Q4 24 | 73.0% | 70.3% | ||
| Q3 24 | 77.0% | 66.6% | ||
| Q2 24 | 81.4% | 64.7% | ||
| Q1 24 | 82.2% | 58.4% |
营业利润率HRMYRGLD
| Q4 25 | 15.8% | 56.2% | ||
| Q3 25 | 27.3% | 64.4% | ||
| Q2 25 | 24.0% | 67.7% | ||
| Q1 25 | 30.4% | 63.6% | ||
| Q4 24 | 27.7% | 65.9% | ||
| Q3 24 | 33.2% | 61.3% | ||
| Q2 24 | 12.4% | 58.6% | ||
| Q1 24 | 33.7% | 50.7% |
净利率HRMYRGLD
| Q4 25 | 9.2% | 24.9% | ||
| Q3 25 | 21.2% | 50.3% | ||
| Q2 25 | 19.8% | 63.1% | ||
| Q1 25 | 24.7% | 58.7% | ||
| Q4 24 | 24.6% | 53.0% | ||
| Q3 24 | 24.8% | 49.7% | ||
| Q2 24 | 6.7% | 46.6% | ||
| Q1 24 | 24.8% | 31.7% |
每股收益（稀释后）HRMYRGLD
| Q4 25 | $0.38 | $1.04 | ||
| Q3 25 | $0.87 | $1.92 | ||
| Q2 25 | $0.68 | $2.01 | ||
| Q1 25 | $0.78 | $1.72 | ||
| Q4 24 | $0.85 | $1.63 | ||
| Q3 24 | $0.79 | $1.46 | ||
| Q2 24 | $0.20 | $1.23 | ||
| Q1 24 | $0.67 | $0.72 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $775.3M | $233.7M |
| 总债务越低越好 | $163.7M | — |
| 股东权益账面价值 | $870.2M | $7.2B |
| 总资产 | $1.3B | $9.5B |
| 负债/权益比越低杠杆越低 | 0.19× | — |
8季度趋势，按日历期对齐
现金及短期投资HRMYRGLD
| Q4 25 | $775.3M | $233.7M | ||
| Q3 25 | $672.6M | $172.8M | ||
| Q2 25 | $565.3M | $248.2M | ||
| Q1 25 | $507.0M | $240.8M | ||
| Q4 24 | $467.2M | $195.5M | ||
| Q3 24 | $410.5M | $127.9M | ||
| Q2 24 | $346.9M | $74.2M | ||
| Q1 24 | $372.4M | $137.9M |
总债务HRMYRGLD
| Q4 25 | $163.7M | — | ||
| Q3 25 | $168.5M | — | ||
| Q2 25 | $172.1M | — | ||
| Q1 25 | $175.7M | — | ||
| Q4 24 | $179.3M | — | ||
| Q3 24 | $182.8M | $0 | ||
| Q2 24 | $186.4M | $50.0M | ||
| Q1 24 | $190.0M | — |
股东权益HRMYRGLD
| Q4 25 | $870.2M | $7.2B | ||
| Q3 25 | $835.1M | $3.4B | ||
| Q2 25 | $773.1M | $3.3B | ||
| Q1 25 | $720.5M | $3.2B | ||
| Q4 24 | $659.2M | $3.1B | ||
| Q3 24 | $596.8M | $3.0B | ||
| Q2 24 | $538.6M | $3.0B | ||
| Q1 24 | $515.4M | $2.9B |
总资产HRMYRGLD
| Q4 25 | $1.3B | $9.5B | ||
| Q3 25 | $1.2B | $4.5B | ||
| Q2 25 | $1.1B | $3.6B | ||
| Q1 25 | $1.1B | $3.5B | ||
| Q4 24 | $999.2M | $3.4B | ||
| Q3 24 | $928.1M | $3.3B | ||
| Q2 24 | $858.4M | $3.3B | ||
| Q1 24 | $847.0M | $3.3B |
负债/权益比HRMYRGLD
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.22× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | 0.31× | 0.00× | ||
| Q2 24 | 0.35× | 0.02× | ||
| Q1 24 | 0.37× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $126.2M | $241.7M |
| 自由现金流经营现金流 - 资本支出 | $126.0M | — |
| 自由现金流率自由现金流/营收 | 51.7% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | 5.61× | 2.58× |
| 过去12个月自由现金流最近4个季度 | $347.9M | — |
8季度趋势，按日历期对齐
经营现金流HRMYRGLD
| Q4 25 | $126.2M | $241.7M | ||
| Q3 25 | $108.7M | $174.0M | ||
| Q2 25 | $79.3M | $152.8M | ||
| Q1 25 | $34.0M | $136.4M | ||
| Q4 24 | $75.6M | $141.1M | ||
| Q3 24 | $70.5M | $136.7M | ||
| Q2 24 | $42.6M | $113.5M | ||
| Q1 24 | $31.1M | $138.3M |
自由现金流HRMYRGLD
| Q4 25 | $126.0M | — | ||
| Q3 25 | $108.7M | — | ||
| Q2 25 | $79.3M | — | ||
| Q1 25 | $33.9M | — | ||
| Q4 24 | $75.0M | — | ||
| Q3 24 | $70.5M | — | ||
| Q2 24 | $42.0M | — | ||
| Q1 24 | $31.1M | — |
自由现金流率HRMYRGLD
| Q4 25 | 51.7% | — | ||
| Q3 25 | 45.4% | — | ||
| Q2 25 | 39.6% | — | ||
| Q1 25 | 18.3% | — | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 37.9% | — | ||
| Q2 24 | 24.3% | — | ||
| Q1 24 | 20.1% | — |
资本支出强度HRMYRGLD
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.0% | — |
现金转化率HRMYRGLD
| Q4 25 | 5.61× | 2.58× | ||
| Q3 25 | 2.14× | 1.37× | ||
| Q2 25 | 1.99× | 1.15× | ||
| Q1 25 | 0.75× | 1.20× | ||
| Q4 24 | 1.53× | 1.31× | ||
| Q3 24 | 1.53× | 1.42× | ||
| Q2 24 | 3.68× | 1.40× | ||
| Q1 24 | 0.81× | 2.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HRMY
暂无分部数据
RGLD
| Gold | $216.9M | 58% |
| Pueblo Viejo | $47.3M | 13% |
| Andacollo | $32.6M | 9% |
| Silver | $32.1M | 9% |
| Other | $27.2M | 7% |
| Copper | $13.7M | 4% |
| Cortez Legacy Zone | $5.4M | 1% |
